Depressed? NYC Screens for People at Risk – NY Times Wed, 13 Apr 2005 A front page article in The New York Times reports that the New York City Department of Health and Mental Hygiene, has instructed doctors at City hospitals – who care for one in four New Yorkers…
Leading Antipsychotic Drugs Come Under New Scrutiny – NYT Tuesday, May 20, 2003 A front page article in The New York Times reveals that the pillars of American psychiatry–including Dr. Jeffrey Lieberman, Dr. John Kane, Dr. William Carpenter–are acknowledging that evidence is lacking to support the claims that the new…
Part II– Mental Health Screening: A Form of Child Abuse–Mother Jones http://www.motherjones.com/news/feature/2005/05/medicating_aliah.html enter subscriber code MJZL6Y Tue, 19 Apr 2005 This is a continuation of the earlier Infomail Re: Mental Health Screening expose by Rob Waters in Mother Jones – A detailed description of (what some would call) collusion by…
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."
“a study published yesterday overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year.”
USA Today reports that last year the pharmaceutical industry "faced the most product liability lawsuits of any other industry."
Industry’s blockbuster sellers–the atypical antipsychotics performed WORSE than their cheaper, non-patented precursors.
A front page report in The New York Times describes a psychotropic drug-induced catastrophe that has befallen patients who obeyed their
psychiatrists, and swallowed the antipsychotic drugs prescribed by psychiatrists who insisted the drugs were for the patients own good.
"I trusted the doctors, I trusted the FDA … and I feel betrayed by both," says Erin Evans, the mother of Rex who was prescribed the ‘atypical’ antipsychotic, Risperdal (risperidone) at age 8.
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
Psychiatry’s professional practice paradigm has received a major blow.
Newly published results (phase II) from the CATIE schizophrenia treatment efficacy study sponsored by the National Institute of Mental Health comparing the most commonly used second generation drug treatments for schizophrenia and depression, is highly disturbing.
